Id |
Subject |
Object |
Predicate |
Lexical cue |
T1 |
0-141 |
Sentence |
denotes |
Platelet activating factor amplifies human neutrophil adherence to bovine endothelial cells: evidence for a lipoxygenase dependent mechanism. |
T1 |
0-141 |
Sentence |
denotes |
Platelet activating factor amplifies human neutrophil adherence to bovine endothelial cells: evidence for a lipoxygenase dependent mechanism. |
T2 |
142-293 |
Sentence |
denotes |
Platelet activating factor (PAF) is a potent lipid mediator that induces the release of leukotrienes and prostaglandins from various cells and tissues. |
T2 |
142-293 |
Sentence |
denotes |
Platelet activating factor (PAF) is a potent lipid mediator that induces the release of leukotrienes and prostaglandins from various cells and tissues. |
T3 |
294-439 |
Sentence |
denotes |
We examined the capacity of PAF alone and in combination with soluble stimuli to enhance eicosanoid synthesis and adherence of human neutrophils. |
T3 |
294-439 |
Sentence |
denotes |
We examined the capacity of PAF alone and in combination with soluble stimuli to enhance eicosanoid synthesis and adherence of human neutrophils. |
T4 |
440-607 |
Sentence |
denotes |
Neutrophils were preincubated with PAF and washed before exposure to the soluble stimuli F-Met-Leu-Phe (FMLP), calcium ionophore A23187, and phorbol myristate acetate. |
T4 |
440-607 |
Sentence |
denotes |
Neutrophils were preincubated with PAF and washed before exposure to the soluble stimuli F-Met-Leu-Phe (FMLP), calcium ionophore A23187, and phorbol myristate acetate. |
T5 |
608-783 |
Sentence |
denotes |
Preincubation of neutrophils with 1 microM PAF enhanced the release of both LTB4 and LTC4 in response to each of the three agonists, in contrast with the unprimed neutrophils. |
T5 |
608-783 |
Sentence |
denotes |
Preincubation of neutrophils with 1 microM PAF enhanced the release of both LTB4 and LTC4 in response to each of the three agonists, in contrast with the unprimed neutrophils. |
T6 |
784-841 |
Sentence |
denotes |
Priming was specific for PAF since lyso-PAF was inactive. |
T6 |
784-841 |
Sentence |
denotes |
Priming was specific for PAF since lyso-PAF was inactive. |
T7 |
842-1015 |
Sentence |
denotes |
Priming concentrations of PAF also augmented the adherence of neutrophils to endothelium in the presence of the soluble agonists A23187, phorbol myristate acetate, and FMLP. |
T7 |
842-1015 |
Sentence |
denotes |
Priming concentrations of PAF also augmented the adherence of neutrophils to endothelium in the presence of the soluble agonists A23187, phorbol myristate acetate, and FMLP. |
T8 |
1016-1148 |
Sentence |
denotes |
The priming effect of PAF on eicosanoid release and neutrophil adherence was shown to have similar time- and dose-dependent effects. |
T8 |
1016-1148 |
Sentence |
denotes |
The priming effect of PAF on eicosanoid release and neutrophil adherence was shown to have similar time- and dose-dependent effects. |
T9 |
1149-1397 |
Sentence |
denotes |
Further, the priming effects of PAF on adherence could be reversed by preincubation of neutrophils with the lipoxygenase inhibitors nordihydroguiaretic acid and 5,8,11,14-ETYA but not by preincubation with the cyclooxygenase inhibitor indomethacin. |
T9 |
1149-1397 |
Sentence |
denotes |
Further, the priming effects of PAF on adherence could be reversed by preincubation of neutrophils with the lipoxygenase inhibitors nordihydroguiaretic acid and 5,8,11,14-ETYA but not by preincubation with the cyclooxygenase inhibitor indomethacin. |
T10 |
1398-1519 |
Sentence |
denotes |
These data demonstrate that PAF amplifies neutrophil adherence to endothelium through a lipoxygenase dependent mechanism. |
T10 |
1398-1519 |
Sentence |
denotes |
These data demonstrate that PAF amplifies neutrophil adherence to endothelium through a lipoxygenase dependent mechanism. |